List of Tables
Table 1. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Primers
Table 3. Key Players of Probes
Table 4. Key Players of Intermediate-scale Synthesis Oligos
Table 5. Key Players of Large-scale Synthesis Oligos
Table 6. Key Players of Linkers and Adaptors
Table 7. Global Solid-phase Oligonucleotide Synthesis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2020-2025)
Table 11. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2026-2031)
Table 13. Solid-phase Oligonucleotide Synthesis Market Trends
Table 14. Solid-phase Oligonucleotide Synthesis Market Drivers
Table 15. Solid-phase Oligonucleotide Synthesis Market Challenges
Table 16. Solid-phase Oligonucleotide Synthesis Market Restraints
Table 17. Global Solid-phase Oligonucleotide Synthesis Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Solid-phase Oligonucleotide Synthesis Market Share by Players (2020-2025)
Table 19. Global Top Solid-phase Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2024)
Table 20. Ranking of Global Top Solid-phase Oligonucleotide Synthesis Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Solid-phase Oligonucleotide Synthesis, Headquarters and Area Served
Table 23. Global Key Players of Solid-phase Oligonucleotide Synthesis, Product and Application
Table 24. Global Key Players of Solid-phase Oligonucleotide Synthesis, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Solid-phase Oligonucleotide Synthesis Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2020-2025)
Table 28. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2026-2031)
Table 30. Global Solid-phase Oligonucleotide Synthesis Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Application (2020-2025)
Table 32. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Application (2026-2031)
Table 34. North America Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031) & (US$ Million)
Table 49. Genescript Company Details
Table 50. Genescript Business Overview
Table 51. Genescript Solid-phase Oligonucleotide Synthesis Product
Table 52. Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 53. Genescript Recent Development
Table 54. GeneArt (Thermofischer) Company Details
Table 55. GeneArt (Thermofischer) Business Overview
Table 56. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product
Table 57. GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 58. GeneArt (Thermofischer) Recent Development
Table 59. Renesas Electronics Corporation Company Details
Table 60. Renesas Electronics Corporation Business Overview
Table 61. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product
Table 62. Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 63. Renesas Electronics Corporation Recent Development
Table 64. DNA 2.0 (ATUM) Company Details
Table 65. DNA 2.0 (ATUM) Business Overview
Table 66. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product
Table 67. DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 68. DNA 2.0 (ATUM) Recent Development
Table 69. OriGene Company Details
Table 70. OriGene Business Overview
Table 71. OriGene Solid-phase Oligonucleotide Synthesis Product
Table 72. OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 73. OriGene Recent Development
Table 74. BBI Company Details
Table 75. BBI Business Overview
Table 76. BBI Solid-phase Oligonucleotide Synthesis Product
Table 77. BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 78. BBI Recent Development
Table 79. Genewiz Company Details
Table 80. Genewiz Business Overview
Table 81. Genewiz Solid-phase Oligonucleotide Synthesis Product
Table 82. Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 83. Genewiz Recent Development
Table 84. Eurofins Genomics Company Details
Table 85. Eurofins Genomics Business Overview
Table 86. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product
Table 87. Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 88. Eurofins Genomics Recent Development
Table 89. Gene Oracle Company Details
Table 90. Gene Oracle Business Overview
Table 91. Gene Oracle Solid-phase Oligonucleotide Synthesis Product
Table 92. Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 93. Gene Oracle Recent Development
Table 94. SBS Genetech Company Details
Table 95. SBS Genetech Business Overview
Table 96. SBS Genetech Solid-phase Oligonucleotide Synthesis Product
Table 97. SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 98. SBS Genetech Recent Development
Table 99. Bio Basic Company Details
Table 100. Bio Basic Business Overview
Table 101. Bio Basic Solid-phase Oligonucleotide Synthesis Product
Table 102. Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025) & (US$ Million)
Table 103. Bio Basic Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. Solid-phase Oligonucleotide Synthesis Picture
Figure 2. Global Solid-phase Oligonucleotide Synthesis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Solid-phase Oligonucleotide Synthesis Market Share by Type: 2024 VS 2031
Figure 4. Primers Features
Figure 5. Probes Features
Figure 6. Intermediate-scale Synthesis Oligos Features
Figure 7. Large-scale Synthesis Oligos Features
Figure 8. Linkers and Adaptors Features
Figure 9. Global Solid-phase Oligonucleotide Synthesis Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Solid-phase Oligonucleotide Synthesis Market Share by Application: 2024 VS 2031
Figure 11. Commercial Case Studies
Figure 12. Academic Research Case Studies
Figure 13. Solid-phase Oligonucleotide Synthesis Report Years Considered
Figure 14. Global Solid-phase Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Solid-phase Oligonucleotide Synthesis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Solid-phase Oligonucleotide Synthesis Market Share by Region: 2024 VS 2031
Figure 17. Global Solid-phase Oligonucleotide Synthesis Market Share by Players in 2024
Figure 18. Global Top Solid-phase Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue in 2024
Figure 20. North America Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Solid-phase Oligonucleotide Synthesis Market Share by Country (2020-2031)
Figure 22. United States Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Solid-phase Oligonucleotide Synthesis Market Share by Country (2020-2031)
Figure 26. Germany Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Share by Region (2020-2031)
Figure 34. China Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Solid-phase Oligonucleotide Synthesis Market Share by Country (2020-2031)
Figure 42. Mexico Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Share by Country (2020-2031)
Figure 46. Turkey Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Genescript Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 50. GeneArt (Thermofischer) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 51. Renesas Electronics Corporation Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 52. DNA 2.0 (ATUM) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 53. OriGene Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 54. BBI Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 55. Genewiz Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 56. Eurofins Genomics Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 57. Gene Oracle Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 58. SBS Genetech Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 59. Bio Basic Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed